Pharmacoeconomic Analysis of Pain Medications Used to Treat Adult Patients with Chronic Back Pain in the United States

References

• Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8:8–20.
   PubMed Web of Science ®Google Scholar
• Jamison, RN, Raymond SA, Slawsby EA, et al. Opioid therapy for chronic noncancer back pain: a randomized prospective study. Spine. 1998;23:2591–2600.
   PubMed Web of Science ®Google Scholar
• Moulin DE, Iezzi A, Amireh R, et al. Randomized trial of oral morphine for chronic non-cancer pain. Lancet. 1996;347:143–147.
   PubMed Web of Science ®Google Scholar
• Haldeman S, Dagenais S. A supermarket approach to the evidence-informed management of chronic low back pain. Spine J. 2008;8:1–7.
   PubMed Web of Science ®Google Scholar
• Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain frequency, clinical evaluation, and treatment patterns from a U.S. national survey. Spine. 1995;20:11–19.
   PubMed Web of Science ®Google Scholar
• Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: impact on health care costs and service use. Spine. 2005;30:1075–1081.
   PubMed Web of Science ®Google Scholar
• Roelofs PDDM, Deyo RA, Koes BW, Scholten RJPM, van Tulder MW. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008;(1):CD000396. doi: 10.1002/14651858.CD000396.pub3
   Google Scholar
• Deshpande A, Furlan A, Mailis-Gagnon A, Atlas S, Turk D. Opioids for chronic low-back pain. Cochrane Database Syst Rev. 2007;(3):CD004959. doi: 10.1002/14651858.CD004959.pub3
   Google Scholar
• Last AR, Hulbert K. Chronic low back pain: evaluation and management. Am Fam Physician. 2009;79:1067–1074.
   PubMed Web of Science ®Google Scholar
• Donner B, Raber M, Zenz M, et al. Experiences with the prescription of opioids: a patient questionnaire. J Pain Symptom Manage. 1998;15:231–234.
   PubMed Web of Science ®Google Scholar
• Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:505–514.
   PubMed Web of Science ®Google Scholar
• Murphy TM. Chronic opioids for chronic low back pain: solution or problem? J Am Board Fam Pract. 1996;9:225–228.
   PubMedGoogle Scholar
• Rasu RS, Vouthy K, Crowl AN, et al. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States. J Manag Care Pharm. 2014;20:921–928.
   Web of Science ®Google Scholar
• Sousa FF, Silva JA. [The metric of pain: theoretical and methodological issues] [in Portuguese]. Rev Dor. 2005;6:469–513.
   Google Scholar
• Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859.
   PubMed Web of Science ®Google Scholar
• Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41:791–801.
   PubMed Web of Science ®Google Scholar
• Cohen JW, Monheit AC, Beauregard KM, et al. The Medical Expenditure Panel Survey: a national health information resource. Inquiry. 1996;33:373–389.
   PubMed Web of Science ®Google Scholar
• Martin BI, Gerkovich MM, Deyo RA, et al. The association of complementary and alternative medicine use and health care expenditures for back and neck problems. Medical care. Dec 2012;50(12):1029–1036.
   PubMed Web of Science ®Google Scholar
• Smith M. Identifying episodes of back pain using Medical Expenditures Panel Survey Data: patient experience, use of services, and chronicity. J Manipulative Physiol Ther. 2010;33:562–575.
   PubMed Web of Science ®Google Scholar
• Cheak-Zamora N, Wyrwich K, McBride T. Reliability and validity of the SF-12v2 in the Medical Expenditure Panel Survey. Qual Life Res. 2009;18:727–735.
   PubMed Web of Science ®Google Scholar
• Ware JEJ, Kosinki M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233.
   PubMed Web of Science ®Google Scholar
• Hanmer J. Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36. Value Health. 2009;12:958–966.
   PubMed Web of Science ®Google Scholar
• Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299:656–664.
   PubMed Web of Science ®Google Scholar
• Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354:581–585.
   PubMed Web of Science ®Google Scholar
• Cherkin DC, Wheeler KJ, Barlow W, Deyo RA. Medication use for low back pain in primary care. Spine. 1998;23:607–614.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440–449.
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Baldwin G. CDC Grand Rounds: Prescription drug overdoses—a US epidemic. MMWR Morb Mortal Wkly Rep. 2012;61:10–13.
   PubMedGoogle Scholar
• van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal antiinflammatory drugs for low back pain. Cochrane Database Syst Rev. 2006;(2):CD000396.
   Google Scholar
• Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage. 1996;11:203–217.
   PubMed Web of Science ®Google Scholar
• Kissin I. Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res. 2013;6:513–529. doi: 10.2147/JPR.S47182
   PubMed Web of Science ®Google Scholar
• Kuijpers T, van Middelkoop M, Rubinstein SM, et al. A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain. Eur Spine J. 2011;20(1):40–50.
   PubMed Web of Science ®Google Scholar
• Kinkade S. Evaluation and treatment of acute low back pain. Am Fam Physician. 2007;75:1181–1188.
   PubMed Web of Science ®Google Scholar
• Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain. 2005;6:21–28.
   PubMed Web of Science ®Google Scholar
• Large RG, Schug SA. Opioids for chronic pain of non-malignant origin—caring or crippling. Health Care Anal. 1995;3:5–11.
   PubMed Web of Science ®Google Scholar
• Lawrence JT, London N, Bohlman HH, Chin KR. Preoperative narcotic use as a predictor of clinical outcome. Spine (Phila Pa 1976). 2008;33:2074–2078.
   PubMed Web of Science ®Google Scholar
• Mahmud MA, Webster BS, Courtney TK, Matz S, Tacci JA, Christiani DC. Clinical management and the duration of disability for work-related low back pain. J Occup Environ Med. 2000;42:1178–1187.
   PubMed Web of Science ®Google Scholar
• Dhalla IA, Gomes T, Mamdani MM, Juurlink DN. Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain. Can Fam Physician. 2012;58:30.
   PubMed Web of Science ®Google Scholar
• Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain. 2003;4:344–350.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO's Pain Ladder. Geneva, Switzerland: World Health Organization; 2011. www.who.int/cancer/palliative/painladder/en/. Accessed November 15, 2011.
   Google Scholar
• Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99:221–227. doi: 10.2105/AJPH.2007.131714
   PubMed Web of Science ®Google Scholar